Gene Logic Inc. Collaboration with Mayo Clinic Reveals Genomic Predictors of Parkinson's Disease
Published: Jun 18, 2007
GAITHERSBURG, Md.--(BUSINESS WIRE)--Gene Logic Inc. (NASDAQ:GLGC) announced today that a collaborative study between its Genomics Division and Mayo Clinic has found biomarkers that predict susceptibility to Parkinson’s disease and age of disease onset. The study was novel in its detailed and comprehensive analysis of genes and their polymorphic variants across a specific biologic pathway. This work may also provide a model for the study of other complex diseases such as Alzheimer’s.